Director's Shareholding

RNS Number : 9717J
Hutchison China Meditech Limited
13 April 2015
 

 

 

 

Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

 

 

Director's Shareholding

 

 

London: Monday, 13 April 2015: Chi-Med received notification on 13 April 2015 that Simon To, Executive Director and Chairman, has purchased 25,000 ordinary shares of US$1.00 each in
Chi-Med (the "Shares") at a price of GBP14.215 per share on 10 April 2015.

 

Following this purchase, Mr To is beneficially interested in 152,000 Shares, representing approximately 0.29% of the current issued share capital of Chi-Med.

 

 

Ends

 

Enquiries

 

   Chi-Med
   Christian Hogg, CEO

Telephone:        +852 2121 8200

   Panmure Gordon (UK) Limited
   Richard Gray
   Andrew Potts
  

Telephone:        +44 20 7886 2500

   Citigate Dewe Rogerson
   Anthony Carlisle
   David Dible

Telephone:        +44 20 7638 9571
Mobile:             +44 7973 611 888
Mobile:             +44 7967 566 919

 

 

About Chi-Med

 

Chi-Med is a China-based healthcare group focused on researching, developing, manufacturing and selling pharmaceuticals and health-related consumer products.  Its Drug R&D Division focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases.  Its China Healthcare Division manufactures, markets and distributes prescription and over-the-counter pharmaceuticals in China.  Its emerging Consumer Products Division focuses on organic and natural consumer products in Asia.

 

Chi-Med is majority owned by the multinational conglomerate Hutchison Whampoa Limited (SEHK:13).  For more information, please visit: www.chi-med.com.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSFISWDFISESL
UK 100

Latest directors dealings